Ang II is considered the ultimate effector of the renin-angiotensin system (RAS) on systemic blood pressure regulation and has been implicated as a major contributor in NAFLD development and progression in recent years [18]. This evidence concerns the gene AGT and metabolic dysfunction-associated steatotic liver disease.